-
4 Crazy Medtech Innovations Shaking Up the Treatment Landscape
Which innovations will transform the market and patient care over the next 5 years?
-
3 Hot Ortho Market Trends to Watch
DRG Medtech experts provide 3 key trends in the orthopedic market space to watch out for and their planning implications from AAOS 2019
-
Global Market Access: 2018 Key Events and Future Impacts
This live session took place on March 26, 2019 Led by expert analysts from Decision Resource Group’s Global Market Access Insights team, this webinar examines key events from 2018 that are shaping...
-
Drug Delivery Device Market
What factors are driving growth in the drug delivery device market, and which companies are leading the way?
-
Digitally-Enabled Med Device Reps
Digitally-Enabled Med Device Reps Did you know that more than half of U.S. surgeons interact with medical device representatives digitally? The Digital MedTech Physician® study...
-
NASH Customer Trends and Planning Considerations
How are customer trends in the NASH market impacting the types of questions you should be asking for planning?
-
The Shift to Outpatient Large-Joint Replacement Surgeries
The Shift to Outpatient Large-Joint Replacement Surgeries Less invasive techniques, better pain management, pressure to minimize costs, and changing reimbursement rules are leading to interesting...
-
Navigating the Rough Seas of Copay Accumulator Programs. Impacts, Trends and Mitigation Strategies for Pharma
This live session took place on February 7th, 2019 During 2018, PBMs began ramping up efforts to address drug spending through Copay Accumulator programs, which prevent manufacturer copay assistance...
-
Global Market Access: Key Events in 2018
Global Market Access: Key Events in 2018 The global market access landscape for pharmaceuticals continued its evolution in 2018 as countries across the globe sought to balance the need for expanding...
-
Immune Checkpoint Inhibitor Trial Landscape – Over 70 Key Trials on the Horizon
Immune checkpoint inhibitors continue to revolutionize the current clinical oncology landscape. DRG experts used Oncology Clinical Trial Monitor data to provide an overview of the late-phase immune...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
